In addition, SETD2 is mutated at low frequency in many other types of cancers such as melanoma, and lung and colon adenocarcinoma (for reviews, see Li et al., 2016; Fahey and Davis, 2017; Chen et al., 2020). This evidence concerns the gene SETD2 and melanoma.